These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24467433)

  • 21. Compulsive activity and anterograde amnesia after zolpidem use.
    Tsai MJ; Tsai YH; Huang YB
    Clin Toxicol (Phila); 2007; 45(2):179-81. PubMed ID: 17364638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dependence on zolpidem in high dose.
    Vartzopoulos D; Bozikas V; Phocas C; Karavatos A; Kaprinis G
    Int Clin Psychopharmacol; 2000 May; 15(3):181-2. PubMed ID: 10870877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extensive craving in high dose zolpidem dependency.
    Svitek J; Heberlein A; Bleich S; Wiltfang J; Kornhuber J; Hillemacher T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):591-2. PubMed ID: 18068286
    [No Abstract]   [Full Text] [Related]  

  • 24. Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008.
    Ben-Hamou M; Marshall NS; Grunstein RR; Saini B; Fois RA
    J Sleep Res; 2011 Dec; 20(4):559-68. PubMed ID: 21481053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.
    Hajak G; Müller WE; Wittchen HU; Pittrow D; Kirch W
    Addiction; 2003 Oct; 98(10):1371-8. PubMed ID: 14519173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases.
    Hajak G; Bandelow B
    Int Clin Psychopharmacol; 1998 Jul; 13(4):157-67. PubMed ID: 9727726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.
    Schifano F; Chiappini S; Corkery JM; Guirguis A
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):270-277. PubMed ID: 30722037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zolpidem and traffic safety - the importance of treatment compliance.
    Verster JC; Volkerts ER; Olivier B; Johnson W; Liddicoat L
    Curr Drug Saf; 2007 Sep; 2(3):220-6. PubMed ID: 18690971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Zolpidem dependence and withdrawal seizure].
    Pitchot W; Ansseau M
    Rev Med Liege; 2009; 64(7-8):407-8. PubMed ID: 19777922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OPPIDUM surveillance program: 20 years of information on drug abuse in France.
    Frauger E; Moracchini C; Le Boisselier R; Braunstein D; Thirion X; Micallef J;
    Fundam Clin Pharmacol; 2013 Dec; 27(6):672-82. PubMed ID: 23510229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial.
    Erman M; Guiraud A; Joish VN; Lerner D
    Sleep; 2008 Oct; 31(10):1371-8. PubMed ID: 18853934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Writing emails as part of sleepwalking after increase in Zolpidem.
    Siddiqui F; Osuna E; Chokroverty S
    Sleep Med; 2009 Feb; 10(2):262-4. PubMed ID: 19059805
    [No Abstract]   [Full Text] [Related]  

  • 34. Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report.
    Aragona M
    Clin Neuropharmacol; 2000; 23(5):281-3. PubMed ID: 11154097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zolpidem and amnestic sleep related eating disorder.
    Najjar M
    J Clin Sleep Med; 2007 Oct; 3(6):637-8. PubMed ID: 17993047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam.
    Gustavsen I; Bramness JG; Skurtveit S; Engeland A; Neutel I; Mørland J
    Sleep Med; 2008 Dec; 9(8):818-22. PubMed ID: 18226959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One rare side effect of zolpidem--sleepwalking: a case report.
    Yang W; Dollear M; Muthukrishnan SR
    Arch Phys Med Rehabil; 2005 Jun; 86(6):1265-6. PubMed ID: 15954071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zolpidem and driving impairment--identifying persons at risk.
    Farkas RH; Unger EF; Temple R
    N Engl J Med; 2013 Aug; 369(8):689-91. PubMed ID: 23923991
    [No Abstract]   [Full Text] [Related]  

  • 40. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.